Author： Nakajima M. Hayashi K. Katayama K.-i. Amano Y. Egi Y. Uehata M. Goto N. Kondo T.
Publisher： Elsevier
ISSN： 0014-2999
Source： European Journal of Pharmacology, Vol.459, Iss.2, 2003-01, pp. : 113-120
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Inflammation Fuels Tumor Progress and Metastasis
Current Pharmaceutical Design, Vol. 21, Iss. 21, 2015-06 ,pp. :
Access to resources
Recommend
Adrenomedullin: A Tumor Progression Factor via Angiogenic Control
Current Cancer Drug Targets, Vol. 6, Iss. 7, 2006-11 ,pp. :
Anti-Angiogenic and Anti-Tumor Properties of Proteasome Inhibitors
Current Cancer Drug Targets, Vol. 5, Iss. 7, 2005-11 ,pp. :
Role of Liprins in the Regulation of Tumor Cell Motility and Invasion
Current Cancer Drug Targets, Vol. 16, Iss. 3, 2016-03 ,pp. :
Recent Developments in the Field of Tumor-Inhibiting Metal Complexes
Current Pharmaceutical Design, Vol. 9, Iss. 25, 2003-10 ,pp. :